GleamWall
中文EN

TVRD Tvardi Therapeutics, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1346830 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-12.7%
TTM EPS YoY64.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-123.1%
ROA-85.2%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets34.3%
Debt / equity0.00x
Current ratio2.86x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.02x
Accruals ratio1.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue—$7.14M
R&D expense$18.01M$23.65M
SG&A expense$8.74M$4.46M
Operating income-$26.75M-$28.11M
Pretax income—-$71.27M
Income tax$0$0
Net income-$18.21M-$29.40M
EBITDA-$26.65M-$28.01M
EPS (basic)-2.46-11.42
EPS (diluted)-3.26-11.42
Dividends declared per share0.00—
Weighted avg. shares (diluted)7.78M2.57M
Balance sheet
Cash & equivalents$20.73M$31.61M
Short-term investments$10.08M—
Receivables—$407,000
Inventory—$900,000
Current assets$31.54M$31.69M
PP&E, net$52,000$84,000
Intangibles$322,000$385,000
Total assets$32.07M$35.20M
Current liabilities$11.04M$10.37M
Total liabilities$11.13M$40.83M
Shareholders' equity$20.95M-$91.13M
Shares outstanding9.38M2.57M
Cash flow statement
Operating cash flow-$23.50M-$18.30M
Capital expenditure—$1.05M
Free cash flow—-$19.35M
Investing cash flow-$10.08M$48.74M
Financing cash flow$22.70M$27.00M
Depreciation & amortization$95,000$95,000
Stock-based compensation$1.40M$319,000

Free plan shows the latest 2 periods; Pro shows all 14 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.